NCT06376669
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Sibley Memorial Hospital Washington D.C., District of Columbia, United States
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,027 public trials
1,169 recruiting studies
Adenocarcinoma trial results
NCT05733598
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
- Locations
-
- Beverly Hills Cancer Center Beverly Hills, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Sylvester Comprehensive Cancer Center (University of Miami Hospital and Clinics) Miami, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
NCT07142005
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +11 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT06222593
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- UB/ Great Lakes Cancer Care Buffalo, New York, United States
NCT05665504
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT06445062
- Conditions
- Adenocarcinoma, CRC, Carcinoma, +25 more
- Locations
-
- Ironwood Cancer and Research Centers Chandler, Arizona, United States
- Mayo Clinic Hospital Phoenix, Arizona, United States
- HonorHealth Research Institute Scottsdale, Arizona, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
NCT07234656
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Aalborg University Hospital Aalborg, Denmark
- Aarhus University Hospital Aarhus, Denmark
- Gødstrup Hospital Herning, Denmark
NCT06553885
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
Recruiting
Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
NCT07197580
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
- Locations
-
- Westmead Hospital Sydney, New South Wales, Australia
- Wollongong Hospital Wollongong, New South Wales, Australia
- Austin Health Heidelberg, Victoria, Australia
- Melbourne Theranostic Innovation Centre (MTIC) Melbourne N., Victoria, Australia
NCT04779554
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +22 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
- University of Vermont Medical Center Burlington, Vermont, United States